Showing results (81-90 of 635) with videos related to
Sort By:
Pageof 64
Archives of Neurology|September 13, 2006
Potential for interferon beta-induced serum antibodies in multiple sclerosis to inhibit endogenous interferon-regulated chemokine/cytokine responses within the central nervous systemAaron M Shapiro, Carolyn S Jack, Yves Lapierre, et al.Clinical Immunology (Orlando, Fla.)|July 6, 2010
Reconstitution of circulating lymphocyte counts in FTY720-treated MS patientsTrina A Johnson, Igor Shames, Mark Keezer, et al.AIDS Research and Human Retroviruses|January 11, 2007
Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseasesJoseph M Antony, Maryam Izad, Amit Bar-Or, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitmentThierry Vincent, Philippe Saikali, Romain Cayrol, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Neuromyelitis optica with hypothalamic involvementAlexandre Y Poppe, Yves Lapierre, Denis Melançon, et al.Annals of Neurology|September 26, 2025
Pro-Inflammatory c-Met+ CD4 T Cells in Multiple SclerosisGautier Breville, Mahdia Benkhoucha, Ayman Rezk, et al.ISRN Neurology|October 11, 2013
Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and MitoxantroneEvgeniy Evdoshenko, Alexey Maslyanskiy, Sergey Lapin, et al.CNS Drugs|June 27, 2013
Safety, tolerability, and efficacy of oral therapies for relapsing-remitting multiple sclerosisJiwon Oh, Paul W O'ConnorTherapeutics and Clinical Risk Management|June 14, 2013
An update of teriflunomide for treatment of multiple sclerosisJiwon Oh, Paul W O'ConnorHandbook of Clinical Neurology|February 11, 2014
Disease-modifying agents in multiple sclerosisPaul W O'Connor, Jiwon OhPageof 64